V2-vasopressin receptor antagonists - mechanism of effect and clinical implications in hyponatraemia

被引：13

作者：

Palm, C ^{[1
]}

Gross, P ^{[1
]}

机构：

[1] Univ Klinikum CG Carus, Dept Med, Div Nephrol, D-01307 Dresden, Germany

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 1999年 / 14卷 / 11期

关键词：

cardiac failure; liver cirrhosis; syndrome of inappropriate antidiuretic hormone secretion; treatment of hyponatraemia; vasopressin; vasopressin receptor antagonists;

D O I：

10.1093/ndt/14.11.2559

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：2559 / 2562

页数：4

共 23 条

[21] IN-VIVO DIURETIC EFFECT OF A NEW NONPEPTIDE ARGININE-VASOPRESSIN ANTAGONIST, OPC-31260, IN CONSCIOUS RATS
TSUBOI, Y
ISHIKAWA, S
FUJISAWA, G
OKADA, K
SAITO, T
[J]. JOURNAL OF ENDOCRINOLOGY, 1994, 143 (02) : 227 - 234
[22] THERAPEUTIC EFFICACY OF THE NONPEPTIDE AVP ANTAGONIST OPC-31260 IN CIRRHOTIC RATS
TSUBOI, Y
ISHIKAWA, SE
FUJISAWA, G
OKADA, K
SAITO, T
[J]. KIDNEY INTERNATIONAL, 1994, 46 (01) : 237 - 244
[23] Upregulation of aquaporin-2 water channel expression in chronic heart failure rat
Xu, DL
Martin, PY
Ohara, M
StJohn, J
Pattison, T
Meng, XZ
Morris, K
Kim, JK
Schrier, RW
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) : 1500 - 1505

← 1 2 3 →